These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 38235716)

  • 21. Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality.
    Tumbarello M; Repetto E; Trecarichi EM; Bernardini C; De Pascale G; Parisini A; Rossi M; Molinari MP; Spanu T; Viscoli C; Cauda R; Bassetti M
    Epidemiol Infect; 2011 Nov; 139(11):1740-9. PubMed ID: 21226988
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-lipopolysaccharide antibody levels in patients with AIDS at the onset of Pseudomonas aeruginosa bacteremia.
    Kumar PN; Collins MS; Pierce PF
    J Acquir Immune Defic Syndr (1988); 1994 Jun; 7(6):587-91. PubMed ID: 8176642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharides and exotoxin A in patients with cystic fibrosis or bacteremia.
    Brauner A; Cryz SJ; Granström M; Hanson HS; Löfstrand L; Strandvik B; Wretlind B
    Eur J Clin Microbiol Infect Dis; 1993 Jun; 12(6):430-6. PubMed ID: 8359163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictors of multidrug-resistant Pseudomonas aeruginosa in neutropenic patients with bloodstream infection.
    Viasus D; Puerta-Alcalde P; Cardozo C; Suárez-Lledó M; Rodríguez-Núñez O; Morata L; Fehér C; Marco F; Chumbita M; Moreno-García E; Fernández-Avilés F; Gutiérrez-Garcia G; Martínez JA; Mensa J; Rovira M; Esteve J; Soriano A; Garcia-Vidal C
    Clin Microbiol Infect; 2020 Mar; 26(3):345-350. PubMed ID: 31295551
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of Mortality in Bloodstream Infections Caused by Pseudomonas aeruginosa and Impact of Antimicrobial Resistance and Bacterial Virulence.
    Recio R; Mancheño M; Viedma E; Villa J; Orellana MÁ; Lora-Tamayo J; Chaves F
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31767719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Bispecific Monoclonal Antibody Targeting Psl and PcrV Enhances Neutrophil-Mediated Killing of
    Long MB; Gilmour A; Kehl M; Tabor DE; Keller AE; Warrener P; Gopalakrishnan V; Rosengren S; Crichton ML; McIntosh E; Giam YH; Keir HR; Brailsford W; Hughes R; Belvisi MG; Sellman BR; DiGiandomenico A; Chalmers JD
    Am J Respir Crit Care Med; 2024 Jul; 210(1):35-46. PubMed ID: 38754132
    [No Abstract]   [Full Text] [Related]  

  • 27. The Impact of Bacterial Biofilms on End-Organ Disease and Mortality in Patients with Hematologic Malignancies Developing a Bloodstream Infection.
    Di Domenico EG; Marchesi F; Cavallo I; Toma L; Sivori F; Papa E; Spadea A; Cafarella G; Terrenato I; Prignano G; Pimpinelli F; Mastrofrancesco A; D'Agosto G; Trento E; Morrone A; Mengarelli A; Ensoli F
    Microbiol Spectr; 2021 Sep; 9(1):e0055021. PubMed ID: 34406812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antibiotic resistance rates for Pseudomonas aeruginosa clinical respiratory and bloodstream isolates among the Veterans Affairs Healthcare System from 2009 to 2013.
    Appaneal HJ; Caffrey AR; Jiang L; Dosa D; Mermel LA; LaPlante KL
    Diagn Microbiol Infect Dis; 2018 Apr; 90(4):311-315. PubMed ID: 29310949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular epidemiology of Pseudomonas aeruginosa bloodstream infection isolates in a non-outbreak setting.
    McCarthy KL; Kidd TJ; Paterson DL
    J Med Microbiol; 2017 Mar; 66(2):154-159. PubMed ID: 28260586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
    Meluleni GJ; Grout M; Evans DJ; Pier GB
    J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Mla pathway is critical for Pseudomonas aeruginosa resistance to outer membrane permeabilization and host innate immune clearance.
    Munguia J; LaRock DL; Tsunemoto H; Olson J; Cornax I; Pogliano J; Nizet V
    J Mol Med (Berl); 2017 Oct; 95(10):1127-1136. PubMed ID: 28844103
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Weighting the impact of virulence on the outcome of Pseudomonas aeruginosa bloodstream infections.
    Sánchez-Diener I; Zamorano L; Peña C; Ocampo-Sosa A; Cabot G; Gómez-Zorrilla S; Almirante B; Aguilar M; Granados A; Calbo E; Rodriguez-Baño J; Rodríguez-López F; Tubau F; Martínez-Martínez L; Navas A; Oliver A
    Clin Microbiol Infect; 2020 Mar; 26(3):351-357. PubMed ID: 31288102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bloodstream infections in neutropenic patients with cancer: differences between patients with haematological malignancies and solid tumours.
    Marin M; Gudiol C; Ardanuy C; Garcia-Vidal C; Calvo M; Arnan M; Carratalà J
    J Infect; 2014 Nov; 69(5):417-23. PubMed ID: 24960295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased risk of death with recurrent Pseudomonas aeruginosa bacteremia.
    McCarthy KL; Paterson DL
    Diagn Microbiol Infect Dis; 2017 Jun; 88(2):152-157. PubMed ID: 28366610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pseudomonas aeruginosa and Burkholderia cenocepacia infections in patients affected by cystic fibrosis: serum resistance and antibody response.
    Savoia D; Deplano C; Zucca M
    Immunol Invest; 2008; 37(1):19-27. PubMed ID: 18214797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bacterial behavior in human blood reveals complement evaders with some persister-like features.
    Pont S; Fraikin N; Caspar Y; Van Melderen L; Attrée I; Cretin F
    PLoS Pathog; 2020 Dec; 16(12):e1008893. PubMed ID: 33326490
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality dynamics of Pseudomonas aeruginosa bloodstream infections and the influence of defective OprD on mortality: prospective observational study.
    Yoon EJ; Kim D; Lee H; Lee HS; Shin JH; Park YS; Kim YA; Shin JH; Shin KS; Uh Y; Jeong SH
    J Antimicrob Chemother; 2019 Sep; 74(9):2774-2783. PubMed ID: 31236593
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outbreak of Pseudomonas aeruginosa and Klebsiella pneumoniae bloodstream infections at an outpatient chemotherapy center.
    Dobbs TE; Guh AY; Oakes P; Vince MJ; Forbi JC; Jensen B; Moulton-Meissner H; Byers P
    Am J Infect Control; 2014 Jul; 42(7):731-4. PubMed ID: 24969124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. P. aeruginosa bloodstream infections among hematological patients: an old or new question?
    Cattaneo C; Antoniazzi F; Casari S; Ravizzola G; Gelmi M; Pagani C; D'Adda M; Morello E; Re A; Borlenghi E; Manca N; Rossi G
    Ann Hematol; 2012 Aug; 91(8):1299-304. PubMed ID: 22349723
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A specific serum IgA antibody discriminates pneumonia from colonization state in patients with Pseudomonas aeruginosa in sputum culture.
    Yamashita M; Hida Y; Sugimoto H; Takahashi N; Kimura H; Nakatomi Y; Yoshida H; Ishizaki T
    J Microbiol Methods; 2010 Sep; 82(3):198-204. PubMed ID: 20538018
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.